About the Company
We do not have any company description for GeneDx Holdings Corp. at the moment.
Exchange
Nasdaq
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest News on GeneDx Holdings Corp.
GeneDx Holdings Corp. (WGS) Rose on Robust Customer Demand
GeneDx Holdings Corp. (NASDAQ:WGS) is a genomics company. The one-month return of GeneDx Holdings Corp. (NASDAQ:WGS) was -1.28%, and its shares gained 897.60% of their value over the last 52 weeks.
GeneDx Holdings Corp.'s (NASDAQ:WGS) institutional investors lost 5.7% ...
To get a sense of who is truly in control of GeneDx Holdings Corp. (NASDAQ:WGS), it is important to understand the ownership structure of the business. The group holding the most number of shares ...
GeneDx Holdings Corp. (WGS) Tops Q3 Earnings and Revenue Estimates
GeneDx Holdings Corp. (WGS) came out with quarterly earnings of $0.04 per share, beating the Zacks Consensus Estimate of a loss of $0.19 per share. This compares to loss of $0.82 per share a year ago.
Will GENEDX HOLDINGS (WGS) Gain on Rising Earnings Estimates?
Investors might want to bet on GeneDx Holdings Corp. (WGS), as earnings estimates for this company have been showing solid ...
GeneDx Holdings Corp. (WGS) Q4 Earnings and Revenues Surpass ... - Nasdaq
GeneDx Holdings Corp. (WGS) came out with quarterly earnings of $0.70 per share, beating the Zacks Consensus Estimate of $0.20 per share. This compares to loss of $0.59 per share a year ago.
GeneDx Holdings Corp. (WGS) Q2 2023 Earnings Call Transcript
GeneDx Holdings Corp. (NASDAQ: WGS) Q2 2023 Results Conference Call August 8, 2023 4:30 PM ET Company Participants Tricia Truehart - Head, IR Katherine Stueland - President and CEO Kevin Feeley - CFO ...
GeneDx Holdings Corp. (NASDAQ:WGS) Shares Acquired by Principal ...
The company has a debt-to-equity ratio of 0.25, a quick ratio of 2.27 and a current ratio of 2.40. GeneDx Holdings Corp. has a 1 year low of $7.72 and a 1 year high of $115.60.
Why GeneDx Holdings Stock Crushed It Again Today
Detailed price information for Genedx Holdings Corp (WGS-Q) from The Globe and Mail including charting and trades.
GeneDx Holdings Corp. (WGS) Q4 2022 Earnings Call Transcript
GeneDx Holdings Corp. (NASDAQ:WGS) Q4 2022 Earnings Conference Call March 14, 2023 4:30 PM ETCompany ParticipantsTricia Truehart - Head IRKatherine Stueland ...
GeneDx Holdings Corp. (NASDAQ: WGS) Investor Alert: Schubert Jonckheer ...
The lawsuit alleges that between January 2022 and August 2022, GeneDx (then named Sema4 Holdings Corp.) misled investors by falsely overstating the capabilities, potential, and commercial ...
GeneDx Holdings Corp. (WGS) Rose on Robust Customer Demand
"GeneDx Holdings Corp. (NASDAQ:WGS) is a specialty laboratory focused on genetic testing for the diagnosis of rare diseases, primarily targeting pediatric patients in neonatal intensive care units and ...
Similar Companies
Loading the latest forecasts...